Published in:
01-02-2022 | Systemic Lupus Erythematosus | Original Article
Serum level of fetuin-A in systemic lupus erythematosus patients: association with atherosclerosis and disease activity
Published in: Clinical Rheumatology | Issue 2/2022
Login to get accessAbstract
Objectives
We aimed in this study to determine the level of serum fetuin-A level in systemic lupus erythematosus patients, assess the correlation between serum fetuin-A level and the activity of disease and the frequency of musculoskeletal manifestations, and detect the frequency of atherosclerosis among these patients by using carotid ultrasonography.
Methods
This case–control study was carried out on 31 SLE patients attending the inpatient and outpatient clinics of Rheumatology and Rehabilitation Department, Faculty of Medicine, Zagazig university hospitals and 31 apparently healthy age- and sex-matched controls between January 1,2017, and December 31, 2018.
Results
There is a highly significant difference between the two studied groups as regard fetuin-A and carotid intima-media thickness. There is a strong positive significant correlation between fetuin-A with C3 and a negative significant correlation between fetuin-A with Anti-dsDNA, SLEDAI, and carotid intima-media thickness in case group.
Conclusion
Fetuin-A levels were decreased in SLE patients, and these levels were inversely correlated with carotid intima-media thickness.
Key Points • Fetuin-A level is a biomarker of atherosclerosis and asses disease activity in SLE patients. |